Switch Email)

In response to the recent NACI recommendations surrounding interchangeability and accelerated rollouts for 2nd doses of COVID-19 Vaccines (e.g. 16 weeks to 12 weeks), we are happy to announce that we have released our new mass function - the “Stay or Switch” email
. This email will allow you to offer patients the choice of whether they would like to stay with the same brand, or move to a waitlist for a different brand for their second dose.
For the complete guide on how to use the Stay/Switch Email feature please see the Help Centre article. 